Acasti Pharma falls on 1-for-6 reverse stock split

Grace Therapeutics

07/07/2023 15:56

** Shares of drug developer Acasti Pharma Inc  ACST.O  down
as much as 11.7% at $0.5251 
    ** Announces 1-for-6 reverse stock split, which will become
effective on July 10  urn:newsml:reuters.com:*:nFWN38T0DB
    ** Co adds that its common shares will trade on
split-adjusted basis on NASDAQ, as of opening of trading on July
10
    ** Including session losses, stock has risen ~5% YTD 

 (Reporting by Amna Karimi in Bengaluru)
 ((Amna.Karimi@thomsonreuters.com; +91 8083261226;))